- Home
- BNR vs TACT Comparison
BNR vs TACT Comparison
Compare BNR & TACT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNR
- TACT
- Stock Information
- Founded
- BNR 2014
- TACT 1996
- Country
- BNR China
- TACT United States
- Employees
- BNR N/A
- TACT N/A
- Industry
- BNR Medical Specialities
- TACT Computer peripheral equipment
- Sector
- BNR Health Care
- TACT Technology
- Exchange
- BNR Nasdaq
- TACT Nasdaq
- Market Cap
- BNR 38.3M
- TACT 42.2M
- IPO Year
- BNR 2020
- TACT 1996
- Fundamental
- Price
- BNR $7.91
- TACT $4.48
- Analyst Decision
- BNR
- TACT Strong Buy
- Analyst Count
- BNR 0
- TACT 1
- Target Price
- BNR N/A
- TACT $5.00
- AVG Volume (30 Days)
- BNR 44.7K
- TACT 58.9K
- Earning Date
- BNR 09-12-2025
- TACT 08-06-2025
- Dividend Yield
- BNR N/A
- TACT N/A
- EPS Growth
- BNR N/A
- TACT N/A
- EPS
- BNR N/A
- TACT N/A
- Revenue
- BNR $72,112,038.00
- TACT $47,949,000.00
- Revenue This Year
- BNR $136.32
- TACT $21.67
- Revenue Next Year
- BNR N/A
- TACT $7.63
- P/E Ratio
- BNR N/A
- TACT N/A
- Revenue Growth
- BNR 0.53
- TACT N/A
- 52 Week Low
- BNR $2.18
- TACT $3.12
- 52 Week High
- BNR $11.12
- TACT $4.89
- Technical
- Relative Strength Index (RSI)
- BNR 52.38
- TACT 65.24
- Support Level
- BNR $8.29
- TACT $4.09
- Resistance Level
- BNR $9.30
- TACT $4.51
- Average True Range (ATR)
- BNR 1.03
- TACT 0.20
- MACD
- BNR -0.16
- TACT 0.01
- Stochastic Oscillator
- BNR 27.91
- TACT 89.58
About BNR Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.
About TACT TransAct Technologies Incorporated
Transact Technologies Inc develops and sells software-driven technology and printing solutions. The company's software is sold under BOHA, AccuDate, Epic, EPICENTRAL, Ithaca, and Printrex brand names. It also provides supplies and consumables used in the printing and scanning activities to restaurant and hospitality, banking, retail, casino and gaming, point of sale automation, lottery, medical, mobile, oil, and gas markets. Majority of the revenue is derived from the casinos and gaming industry followed by the Foodservice technology market. Its geographical segments are the United States and International, of which the majority of its revenue comes from the United States.